Rasio rega marang bathi Cardio Diagnostics Holdings Inc. (CDIO)

This price chart illustrating value trends for Cardio Diagnostics (CDIO) reflects the asset's dynamics, where the P/E ratio stands at -0.80. Cardio Diagnostics (CDIO) is developing an AI environment for cardiac diagnostics that integrates machine learning with genetics to create a powerful data effect. US laboratories ensure the accuracy of early risk screening. The business is currently scaling personalized tests, implementing intelligent algorithms into clinical practice for heart attack prevention.

Geopolitical fragmentation and logistical barriers in reagent supply are hindering the expansion of Cardio Diagnostics (CDIO) into emerging markets. These operational complexities directly impact net income, which determines the denominator of the calculated ratio. This multiple relates the market value of the business to its actual earnings, measuring the investment payback period. High values signal inflated expectations, while low values indicate undervaluation. By analyzing the weighted average P/E of Cardio Diagnostics (CDIO), an investor assesses whether the market price is aligned with current profitability.